Mesenchymal stem cells in allergic diseases: Current status

Allergic diseases, which include asthma, allergic skin diseases, allergic rhinitis and allergic conjunctivitis, have already garnered worldwide public health attention over recent decades. Mesenchymal stem cells (MSCs) have gradually emerged as a potential method for treating allergic diseases due t...

Full description

Saved in:
Bibliographic Details
Published in:Allergology international 2020-01, Vol.69 (1), p.35-45
Main Authors: Li, He, Tian, Yunzhe, Xie, Lihui, Liu, Xiuxing, Huang, Zhaohao, Su, Wenru
Format: Article
Language:English
Subjects:
Allergic disease
Asthma
Exosomes
Immunomodulation
Mesenchymal stem cells
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Allergic diseases, which include asthma, allergic skin diseases, allergic rhinitis and allergic conjunctivitis, have already garnered worldwide public health attention over recent decades. Mesenchymal stem cells (MSCs) have gradually emerged as a potential method for treating allergic diseases due to their immunosuppressive characteristics, tissue repair ability and secretion of various biological factors. This potential of MSC-based therapy has been confirmed in clinical and preclinical studies, which report the therapeutic benefits of MSCs for various allergic diseases and explore the antiallergic mechanisms. In this review, we focus on the discoveries and biological mechanisms of MSCs as a therapeutic tool in allergic diseases. We discuss the challenges of conducting MSC studies as well as future directions.
ISSN:1323-8930
1440-1592
DOI:10.1016/j.alit.2019.08.001